secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2023-08-18T23:59:59+00:00
Accession:  0001213900-23-069046
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TradeUP extends business combination deadline to Sept 19 with $37,432.70 deposit from Estrella
--------------------------------------------------------------------------------

- Extension fee of $37,432.70 ($0.05 per share) deposited into trust account to extend deadline to September 19, 2023.
- Payment made by merger partner Estrella Biopharma under Merger Agreement; recorded as unsecured promissory note.
- Note convertible into shares at $10/share if business combination closes; repayable if deal terminates.
- Company retains ability to extend monthly through July 14, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000121390023069046/0001213900-23-069046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000121390023069046/ea183872-8k425_tradeup.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-069046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer